BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21228719)

  • 1. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature.
    Rodgers GM
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):86-8. PubMed ID: 21228719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-mediated coagulopathy: a case report.
    Naoum JJ
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):13S-7S. PubMed ID: 19558280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody induced coagulopathy from bovine thrombin use during partial nephrectomy.
    Pavlovich CP; Battiwalla M; Rick ME; Walther MM
    J Urol; 2001 May; 165(5):1617. PubMed ID: 11342931
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombin products: economic impact of immune-mediated coagulopathies and practical formulary considerations.
    Voils SA
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):18S-22S. PubMed ID: 19558281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of antibodies to the topical hemostat bovine thrombin.
    Randleman CD; Singla NK; Renkens KL; Souza S; Pribble JP; Alexander WA
    J Am Coll Surg; 2010 Dec; 211(6):798-803. PubMed ID: 20980172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical thrombins: benefits and risks.
    Lomax C; Traub O
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):8S-12S. PubMed ID: 19558279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
    Ofosu FA; Crean S; Reynolds MW
    Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine thrombin: history, use, and risk in the surgical patient.
    Diesen DL; Lawson JH
    Vascular; 2008; 16 Suppl 1():S29-36. PubMed ID: 18544303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
    Lo CY; Jones C; Glader B; Zehnder JL
    Pediatr Blood Cancer; 2010 Dec; 55(6):1195-7. PubMed ID: 20979176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical recombinant human thrombin in surgical hemostasis.
    Bowman LJ; Anderson CD; Chapman WC
    Semin Thromb Hemost; 2010 Jul; 36(5):477-84. PubMed ID: 20632245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.
    Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA
    J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihuman factor V antibodies after use of relatively pure bovine thrombin.
    Lawson JH; Lynn KA; Vanmatre RM; Domzalski T; Klemp KF; Ortel TL; Niklason LE; Parker W
    Ann Thorac Surg; 2005 Mar; 79(3):1037-8. PubMed ID: 15734434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative coagulopathy in a pediatric patient after exposure to bovine topical thrombin.
    Crow SS; Sullivan VV; Aysola AE; Key NS; Harker-Murray P; Foker JE; Steiner ME
    Ann Thorac Surg; 2007 Apr; 83(4):1547-9. PubMed ID: 17383385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The coagulation cascade and surgical hemostasis. Introduction.
    Voils SA
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):1S. PubMed ID: 19558277
    [No Abstract]   [Full Text] [Related]  

  • 15. Cross-reactivity of rabbit anti-bovine thrombin IgGs with human alpha-thrombin and a recombinant version of human thrombin (Recothrom).
    He Zhu ; Hoppensteadt D; Cunanan J; Fareed J
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):273-80. PubMed ID: 20547555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe coagulopathy following intraoperative use of topical thrombin.
    Sarfati MR; Dilorenzo DJ; Kraiss LW; Galt SW
    Ann Vasc Surg; 2004 May; 18(3):349-51. PubMed ID: 15354638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving hemostasis in the surgical field.
    Boucher BA; Traub O
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):2S-7S. PubMed ID: 19558278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk and clinical significance of developing antibodies induced by topical thrombin preparations.
    Dorion RP; Hamati HF; Landis B; Frey C; Heydt D; Carey D
    Arch Pathol Lab Med; 1998 Oct; 122(10):887-94. PubMed ID: 9786349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in topical thrombins.
    Kessler CM; Ortel TL
    Thromb Haemost; 2009 Jul; 102(1):15-24. PubMed ID: 19572062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
    Clark JA; Humphries JE; Crean S; Reynolds MW
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):107-14. PubMed ID: 20014051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.